Twin Focus Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Twin Focus Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-465	Closed	-$243K	–	219
2023 Q2	$243K	Sell	465 -297	-39%	-$160K	0.05%	190
2023 Q1	$439K	Buy	762 +44	+6%	+$24.8K	0.09%	114
2022 Q4	$395K	Buy	718 +83	+13%	+$44K	0.08%	121
2022 Q3	$322K	Buy	635 +1	+0.2%	+$560	0.08%	137
2022 Q2	$344K	Buy	634 +9	+1%	+$4.95K	0.08%	132
2022 Q1	$369K	Sell	625 -8	-1%	-$4.6K	0.07%	136
2021 Q4	$422K	Buy	633 +225	+55%	+$140K	0.08%	129
2021 Q3	$233K	Buy	+408	New	+$224K	0.05%	160

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Twin Focus Capital Partners's TMO Position: Q3 2023 in Review

Twin Focus Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 465 shares — an estimated $243K sold.

Twin Focus Capital Partners first reported a position in TMO in Q3 2021 and held it in 8 quarters. The position peaked at $439K in Q1 2023. 2,366 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Twin Focus Capital Partners reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
Twin Focus Capital Partners sold 465 Thermo Fisher Scientific shares in Q3 2023, an estimated $243K.
Twin Focus Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 8 quarters.
Twin Focus Capital Partners's Thermo Fisher Scientific position peaked at $439K in Q1 2023.
2,366 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.